Philippine financial markets are heading into the week on a cautious footing as renewed threats by Iran to potentially close the Strait of Hormuz inject fresh volatility into global oil supply expectations and inflation outlooks, according to Rizal Commercial Banking Corp. chief economist Michael Ricafort.
The Philippine stock market is navigating a mixed outlook as the PSEi contends with renewed foreign selling, offset partially by improving domestic investor sentiment and anticipated foreign inflows into the local bond market.
Philippine financial markets are expected to remain fragile this week, with investors bracing for continued volatility as risk aversion dominates sentiment and the benchmark index struggles to regain footing above key levels.
The Philippine Stock Exchange index (PSEi) slid 1.3 percent to 6,384.58, extending profit-taking for a second session after touching seven- to nine-month highs. Even so, the benchmark remains comfortably above the 6,000 mark, keeping the broader uptrend intact and suggesting the pullback is more consolidation than reversal.
A P45-million biotechnology investment is bringing artificial intelligence-powered drug discovery to the Philippines, with a new research facility expected to create 35 high-value jobs and develop potential treatments for neurological disorders.
Higher input costs and expansion-related expenses outpaced revenue growth at Fruitas Holdings Inc. in the first nine months of 2026, dragging down earnings despite an almost 19-percent increase in sales.
Retail prices of several food staples edged higher in early November, led by rice, carrots and red onions, although pork and some other commodities remained cheaper than a year ago, reflecting uneven price pressures in the food market.
Farmgate prices of palay rose nearly 34 percent year-on-year in October as a sharp production slump, rising farm input costs and weather disruptions tightened supply, offering farmers better selling prices but raising concerns over the next harvests.